2019 annual financial data
Vistagen Therapeutics 2019 Operating margin
Vistagen Therapeutics 2019 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -24,556,300 USD and net income was -24,589,600 USD.
Operating cash flow was -14,527,500 USD.
Get free Vistagen Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -24,556,300 USD
- Net income
- -24,589,600 USD
- Operating cash flow
- -14,527,500 USD